Pilot studies have indicated that single-cell omics (scOmics) approaches play an important role in studying the function of cells and revealing the difference between individual cells. Single-cell technologies can analyze the cell at different levels, including the genome, transcriptome, epigenome, as well as proteome. The results have been considered as critical data for analyzing disease biology and predicting the efficacy of novel drugs or therapies. With the extensive experiences and advanced platforms, Creative Biolabs has developed a wide variety of single-cell omics services to identify the role of immunity and microbiome in disease treatments, especially for cancer therapy.
Single Cell Omics Solutions for Tumor Infiltrated Immune Cells
Tumor-infiltrating immune cells have been regarded as attractive markers for revealing the immune responses and tumor control in various cancer immunotherapy. scOmics technologies have been widely used for analyzing the heterogeneity of cells and molecules in the tumor microenvironment (TME). Meanwhile, scOmics analysis of tumor-infiltrating immune cells is also critical to determine the cell interactions in cancer research. Single Cell now offers a collection of single-cell omics services for quantifying different cell types, such as T cells, B cells, dendritic cells (DCs), natural killer cells (NKs), macrophages, myeloid-derived suppressor cells (MDSCs), as well as neutrophils. The molecular mechanisms and the phenotypes of various tumor-infiltrating immune cells can provide further information on revealing cellular interactions, predicting the results of different therapeutic interventions, and studying tumor development and treatment.
Learn more: single cell microbiome
Comments